By Nigam Arora & Dr. Natasha Arora
Congratulations! Kansas City Southern (KSU) buyout is on track. KSU is long from an average of $169.71. The implied value of the buyout is $300. This consists of $90 in cash and 2.884 shares of CP. KSU is trading at $283 as of this writing. $283 represents a 67% gain.
To date 167 of Arora Portfolio companies have been bought out producing a fortune for long time subscribers. This record is better than research firms charging more than $50,000 per year.
What To Do Now
KSU stock will now move based on any move in Canadian Pacific Railway Limited (CP) stock. CP is trading at $69.11 as of this writing.
In the very long term, due to the synergies from the buyout, CP stock has the potential to go over $100. However, in the short to medium term, there are no triggers for a major move up. On the other hand in a market correction, CP stock can easily fall to the mid $50s.
What to do now comes down to personal preference. Consider making a decision based on the information given above.
CP will continue to be followed.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES,
TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
